← Back to all trials
Recruiting
NCT05326750
Non-invasive Neurostimulation as a Tool for Diagnostics and Management for Neurodegenerative Diseases
Conditions: Alzheimer Disease, Frontotemporal Dementia, Dementia With Lewy Bodies
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Phase: NA
Enrollment: 200
Sponsor: Kuopio University Hospital
Location: Kuopio University Hospital Kuopio
Summary
Double blinded, sham-controlled, randomized trial on repeated transcranial alternating current brain stimulation (tACS) in neurodegenerative diseases. The investigators will evaluate whether a 4-times daily repeated stimulation with gamma tACS on the posterior parietal cortex can improve symptoms in patients with neurodegenerative diseases, including dementia with Lewy Bodies, Alzheimer's disease, idiopathic normal pressure hydrocephalus and Frontotemporal dementia.
Eligibility Criteria
Inclusion Criteria:
* Mild Cognitive Impairment due to Alzheimer's disease
* Dementia with Lewy Bodies
* Frontotemporal dementia
* Idiopathic normal pressure hydrocephalus (iNPH)
Exclusion Criteria:
* History of seizures
* Pregnancy
* Metal implants in the head (except dental fillings)
* Electronic implants (i.e. pace-maker, implanted medical pump)
* Age \
Source: ClinicalTrials.gov (NCT05326750). StuddyBuddy aggregates publicly available trial information.
